Opinion Article, J Pharm Sci Emerg Drugs Vol: 11 Issue: 2

Emerging Technologies for Non-Invasive Drug Delivery: From Inhalation to Implants

Stephen Lyn^*

¹Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznań, Poland

*Corresponding Author: Stephen Lyn
Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznań, Poland
E-mail: lynstephen@ump.edu.pl

Received date: 22 March, 2023, Manuscript No. JPSED-23-98674;

Editor assigned date: 24 March, 2023, Pre QC. JPSED-23-98674(PQ);

Reviewed date: 15 April, 2023, QC No. JPSED-23-98674;

Revised date: 22 April, 2023, Manuscript No. JPSED-23-98674(R);

Published date: 28 April, 2023, DOI: 10.4172/2380-9477.1000138.

Citation: Lyn S (2023) Emerging Technologies for Non-Invasive Drug Delivery: From Inhalation to Implants. J Pharm Sci Emerg Drugs 11:2.

Abstract

Keywords: Drug Delivery

Description

Advancements in drug delivery technologies have revolutionized the field of medicine, enabling more effective and targeted treatments while minimizing side effects. One of the key areas of focus is noninvasive drug delivery, which aims to administer therapeutic substances without the need for injections or invasive procedures. The emerging technologies for non-invasive drug delivery, highlighting the progress made in inhalation-based systems and implantable devices.

Inhalation-based drug delivery systems

Inhalation-based drug delivery systems have gained significant attention due to their ability to directly target the respiratory system, which offers several advantages. The pulmonary route provides a large surface area and extensive vascularization, allowing for rapid and efficient drug absorption. One prominent example of inhalation-based drug delivery is the use of nebulizers, which convert liquid medications into aerosols that can be inhaled by patients. Nebulizers have been widely used for the treatment of respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD). However, traditional nebulizers have limitations in terms of portability and precise dosing.

To overcome these limitations, researchers have been developing advanced inhalation devices, such as Dry Powder Inhalers (DPIs) and Metered-Dose Inhalers (MDIs). DPIs deliver powdered medication directly to the lungs, while MDIs deliver a metered dose of medication in the form of a mist or spray. These devices offer improved portability, dose accuracy, and ease of use. Furthermore, researchers are exploring nanotechnology-based formulations to enhance drug delivery efficiency, increase drug stability, and enable targeted delivery to specific regions of the respiratory tract.

Implantable devices for drug Delivery

Implantable devices are another promising avenue for non-invasive drug delivery. These devices are designed to be surgically implanted in the body and release medications in a controlled manner over an extended period. One of the most well-known examples is the contraceptive implant, which provides long-term contraception by releasing hormones into the bloodstream. Implantable drug delivery systems offer several advantages, including sustained drug release, reduced dosing frequency, and improved patient compliance.

Recent advancements in implantable technologies have expanded their applications beyond contraception. For instance, implantable devices are being developed for the treatment of chronic conditions such as diabetes, where they can provide continuous and personalized drug delivery based on real-time glucose monitoring. These systems aim to optimize therapy, minimize the risk of complications, and improve patient quality of life.

Researchers are also exploring the use of biodegradable implants that gradually release drugs and then safely degrade within the body. These implants eliminate the need for surgical removal, reducing the invasiveness of the procedure. Furthermore, the integration of sensors and wireless communication capabilities into implantable devices enables real-time monitoring of drug release, patient response, and other important parameters.

Non-invasive drug delivery technologies have the potential to transform healthcare by offering improved treatment options, enhanced patient compliance, and reduced healthcare costs. Inhalation-based systems, such as DPIs and MDIs, offer efficient drug delivery to the respiratory system, while implantable devices provide sustained release of medications for a variety of conditions. Continued research and development in these areas will likely lead to further advancements, addressing challenges related to dose accuracy, targeted delivery, and biocompatibility.